✦ LIBER ✦

27A Targeting the PI3K/mTOR pathway in genetically engineered mouse models of advanced prostate cancer

✍ Scribed by A. Patnaik; K. Courtney; S. Signoretti; M. Loda; A. Grant; I. Pedrosa; E. Lunsford; J. Frangioni; P. Pandolfi; L. Cantley

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The PI3K/AKT/mTOR Pathway as a Therapeut

✍ Slomovitz, B. M.; Coleman, R. L. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 996 KB

The Dual PI3K/mTOR Inhibitor NVP-BEZ235

✍ Jatin Roper; Michael P. Richardson; Wei Vivian Wang; Larissa Georgeon Richard; W 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Targeted RNA interference of PI3K pathwa

✍ Lindsey N. Jackson; Piotr G. Rychahou; B. Mark Evers 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 47 KB

646 Statins Inhibit the PI3K/AKT/mTOR Pa

✍ Rutger J. Jacobs; Liudmila L. Kodach; Philip Voorneveld; Jarom Heijmans; Sander 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Inhibition of PI-3K restores nuclear p27

✍ Kelly-Spratt, K S; Philipp-Staheli, J; Gurley, K E; Hoon-Kim, K; Knoblaugh, S; K 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 608 KB

883 Investigating MEK and PI3K/mTor Inhi

✍ M. Raja; M. Zverev; P. Shaw; A. Clarke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 51 KB